Cencora COR has outperformed the market over the past 5 years by 8.2% on an annualized basis producing an average annual return of 20.8%. Currently, Cencora has a market capitalization of $47.04 ...

Shares of Cencora Inc. COR shed 1.28% to $243.59 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 0.27% to 6,051.97 and ...

Wells Fargo & Company increased their price objective on Cencora from $237.00 to $251.00 and gave the stock an “equal weight” rating in a research note on Wednesday, January 29th. Robert W.

Headquartered in Conshohocken, Pennsylvania, Cencora, Inc. (COR) is a leading pharmaceutical services company dedicated to enhancing global healthcare. With a market cap of $47.7 billion ...

The Chicago White Sox have been looking to move outfielder Luis Robert Jr. for months, and they may finally get their chance during spring training. The Athletic’s Jayson Stark recently ...

Growth at a reasonable price, or GARP, is an excellent strategy to earn quick investment profits. The GARP approach helps identify stocks priced below the market or any suitable target determined ...

Looking at the universe of stocks we cover at Dividend Channel, on 2/14/25, Cencora Inc (Symbol: COR), Bio-Techne Corp (Symbol: TECH), and Eli Lilly (Symbol: LLY) will all trade ex-dividend for ...

Collis will retire as President and Chief Executive Officer of the Company and transition to the role of Executive Chair of the Cencora Board of Directors, effective October 1, 2024. Robert P.

Healthcare and pharmaceuticals have the second largest exposure. Distributors such as McKesson Corp. and Cencora Inc. could face disruption, with the analysts noting government spending is related ...